Measles

Paul A. Rota, William J Moss, Makoto Takeda, Rik L. De Swart, Kimberly M. Thompson, James L. Goodson

Research output: Contribution to journalArticle

Abstract

Measles is an infectious disease in humans caused by the measles virus (MeV). Before the introduction of an effective measles vaccine, virtually everyone experienced measles during childhood. Symptoms of measles include fever and maculopapular skin rash accompanied by cough, coryza and/or conjunctivitis. MeV causes immunosuppression, and severe sequelae of measles include pneumonia, gastroenteritis, blindness, measles inclusion body encephalitis and subacute sclerosing panencephalitis. Case confirmation depends on clinical presentation and results of laboratory tests, including the detection of anti-MeV IgM antibodies and/or viral RNA. All current measles vaccines contain a live attenuated strain of MeV, and great progress has been made to increase global vaccination coverage to drive down the incidence of measles. However, endemic transmission continues in many parts of the world. Measles remains a considerable cause of childhood mortality worldwide, with estimates that >100,000 fatal cases occur each year. Case fatality ratio estimates vary from <0.01% in industrialized countries to >5% in developing countries. All six WHO regions have set goals to eliminate endemic transmission of MeV by achieving and maintaining high levels of vaccination coverage accompanied by a sensitive surveillance system. Because of the availability of a highly effective and relatively inexpensive vaccine, the monotypic nature of the virus and the lack of an animal reservoir, measles is considered a candidate for eradication.

Original languageEnglish (US)
Article number16049
JournalNature Reviews Disease Primers
Volume2
DOIs
StatePublished - Jul 14 2016

Fingerprint

Measles
Measles virus
Subacute Sclerosing Panencephalitis
Measles Vaccine
Vaccination
Conjunctivitis
Viral RNA
Gastroenteritis
Blindness
Exanthema
Cough
Immunosuppression
Developing Countries
Communicable Diseases
Immunoglobulin M
Pneumonia
Fever
Vaccines
Viruses
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rota, P. A., Moss, W. J., Takeda, M., De Swart, R. L., Thompson, K. M., & Goodson, J. L. (2016). Measles. Nature Reviews Disease Primers, 2, [16049]. https://doi.org/10.1038/nrdp.2016.49

Measles. / Rota, Paul A.; Moss, William J; Takeda, Makoto; De Swart, Rik L.; Thompson, Kimberly M.; Goodson, James L.

In: Nature Reviews Disease Primers, Vol. 2, 16049, 14.07.2016.

Research output: Contribution to journalArticle

Rota, PA, Moss, WJ, Takeda, M, De Swart, RL, Thompson, KM & Goodson, JL 2016, 'Measles', Nature Reviews Disease Primers, vol. 2, 16049. https://doi.org/10.1038/nrdp.2016.49
Rota PA, Moss WJ, Takeda M, De Swart RL, Thompson KM, Goodson JL. Measles. Nature Reviews Disease Primers. 2016 Jul 14;2. 16049. https://doi.org/10.1038/nrdp.2016.49
Rota, Paul A. ; Moss, William J ; Takeda, Makoto ; De Swart, Rik L. ; Thompson, Kimberly M. ; Goodson, James L. / Measles. In: Nature Reviews Disease Primers. 2016 ; Vol. 2.
@article{ff5444ad3a054226a5680577ba425466,
title = "Measles",
abstract = "Measles is an infectious disease in humans caused by the measles virus (MeV). Before the introduction of an effective measles vaccine, virtually everyone experienced measles during childhood. Symptoms of measles include fever and maculopapular skin rash accompanied by cough, coryza and/or conjunctivitis. MeV causes immunosuppression, and severe sequelae of measles include pneumonia, gastroenteritis, blindness, measles inclusion body encephalitis and subacute sclerosing panencephalitis. Case confirmation depends on clinical presentation and results of laboratory tests, including the detection of anti-MeV IgM antibodies and/or viral RNA. All current measles vaccines contain a live attenuated strain of MeV, and great progress has been made to increase global vaccination coverage to drive down the incidence of measles. However, endemic transmission continues in many parts of the world. Measles remains a considerable cause of childhood mortality worldwide, with estimates that >100,000 fatal cases occur each year. Case fatality ratio estimates vary from <0.01{\%} in industrialized countries to >5{\%} in developing countries. All six WHO regions have set goals to eliminate endemic transmission of MeV by achieving and maintaining high levels of vaccination coverage accompanied by a sensitive surveillance system. Because of the availability of a highly effective and relatively inexpensive vaccine, the monotypic nature of the virus and the lack of an animal reservoir, measles is considered a candidate for eradication.",
author = "Rota, {Paul A.} and Moss, {William J} and Makoto Takeda and {De Swart}, {Rik L.} and Thompson, {Kimberly M.} and Goodson, {James L.}",
year = "2016",
month = "7",
day = "14",
doi = "10.1038/nrdp.2016.49",
language = "English (US)",
volume = "2",
journal = "Nature Reviews Disease Primers",
issn = "2056-676X",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Measles

AU - Rota, Paul A.

AU - Moss, William J

AU - Takeda, Makoto

AU - De Swart, Rik L.

AU - Thompson, Kimberly M.

AU - Goodson, James L.

PY - 2016/7/14

Y1 - 2016/7/14

N2 - Measles is an infectious disease in humans caused by the measles virus (MeV). Before the introduction of an effective measles vaccine, virtually everyone experienced measles during childhood. Symptoms of measles include fever and maculopapular skin rash accompanied by cough, coryza and/or conjunctivitis. MeV causes immunosuppression, and severe sequelae of measles include pneumonia, gastroenteritis, blindness, measles inclusion body encephalitis and subacute sclerosing panencephalitis. Case confirmation depends on clinical presentation and results of laboratory tests, including the detection of anti-MeV IgM antibodies and/or viral RNA. All current measles vaccines contain a live attenuated strain of MeV, and great progress has been made to increase global vaccination coverage to drive down the incidence of measles. However, endemic transmission continues in many parts of the world. Measles remains a considerable cause of childhood mortality worldwide, with estimates that >100,000 fatal cases occur each year. Case fatality ratio estimates vary from <0.01% in industrialized countries to >5% in developing countries. All six WHO regions have set goals to eliminate endemic transmission of MeV by achieving and maintaining high levels of vaccination coverage accompanied by a sensitive surveillance system. Because of the availability of a highly effective and relatively inexpensive vaccine, the monotypic nature of the virus and the lack of an animal reservoir, measles is considered a candidate for eradication.

AB - Measles is an infectious disease in humans caused by the measles virus (MeV). Before the introduction of an effective measles vaccine, virtually everyone experienced measles during childhood. Symptoms of measles include fever and maculopapular skin rash accompanied by cough, coryza and/or conjunctivitis. MeV causes immunosuppression, and severe sequelae of measles include pneumonia, gastroenteritis, blindness, measles inclusion body encephalitis and subacute sclerosing panencephalitis. Case confirmation depends on clinical presentation and results of laboratory tests, including the detection of anti-MeV IgM antibodies and/or viral RNA. All current measles vaccines contain a live attenuated strain of MeV, and great progress has been made to increase global vaccination coverage to drive down the incidence of measles. However, endemic transmission continues in many parts of the world. Measles remains a considerable cause of childhood mortality worldwide, with estimates that >100,000 fatal cases occur each year. Case fatality ratio estimates vary from <0.01% in industrialized countries to >5% in developing countries. All six WHO regions have set goals to eliminate endemic transmission of MeV by achieving and maintaining high levels of vaccination coverage accompanied by a sensitive surveillance system. Because of the availability of a highly effective and relatively inexpensive vaccine, the monotypic nature of the virus and the lack of an animal reservoir, measles is considered a candidate for eradication.

UR - http://www.scopus.com/inward/record.url?scp=85006207365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006207365&partnerID=8YFLogxK

U2 - 10.1038/nrdp.2016.49

DO - 10.1038/nrdp.2016.49

M3 - Article

C2 - 27411684

AN - SCOPUS:85006207365

VL - 2

JO - Nature Reviews Disease Primers

JF - Nature Reviews Disease Primers

SN - 2056-676X

M1 - 16049

ER -